Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neurofibromatosis 1 2Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Glioblastoma 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Attention Deficit Disorder with Hyperactivity 1Acute Kidney Injury 1

Interventions

Transcranial Direct Current Stimulation 2Exercise 2mazdutide 1lime 1fasudil 1enzalutamide 1Time 1Tablets 1Standard of Care 1Referral and Consultation 1Ramipril 1Radiosurgery 1Prednisone 1Population Groups 1Palliative Care 1Organization and Administration 1Modafinil 1Methods 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Low-Level Light Therapy 1Hormones 1Health 1Gonadotropin-Releasing Hormone 1Electroencephalography 1Drug Delivery Systems 1Data Collection 1Anesthesia, General 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Acetylcysteine × 1 year × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡